Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03190161 · ClinicalTrials.gov registry record · NA
Music to Reduce Use of Smoking in Patients With Schizophrenia
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03190161: Completed NA study, sponsored by NYU Langone Health.
NCT03190161 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03190161, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.
Primary Outcome
Measures Pleasure Pre Music Session
Interventions
- BEHAVIORAL Music session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2018-09-17 |
| Phase | NA |
What the finished NCT03190161 record still lists
NCT03190161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Music session is the first listed.
NCT03190161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03190161 about?
NCT03190161 is a clinical study titled "Music to Reduce Use of Smoking in Patients With Schizophrenia". The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder...
What is the current status of trial NCT03190161?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-03-09. Estimated completion is 2018-09-17.
What interventions are being tested in trial NCT03190161?
The interventions under investigation include: Music session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03190161?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03190161's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI